Bowman & CO S.C. Medtronic PLC Transaction History

Bowman & CO S.C.

$170 Million
Q2 2024

A detailed history of Bowman & CO S.C. transactions in Medtronic PLC stock. As of the latest transaction made, Bowman & CO S.C. holds 15,956 shares of MDT stock, worth $1.43 Million. This represents 0.74% of its overall portfolio holdings.

Number of Shares

15,956

Previous 14,505 10.0%

Holding current value

$1.43 Million

Previous $1.26 Million 0.71%

% of portfolio

0.74%

Previous 0.78%

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Jul 24, 2024	BUY	$78.71 - $87.02 $114,208 - $126,266	1,451 Added 10.0%	15,956 $1.26 Million
Q1 2024 Apr 15, 2024	SELL	$82.84 - $88.09 $14,579 - $15,503	-176 Reduced 1.2%	14,505 $1.26 Million
Q4 2023 Jan 10, 2024	BUY	$69.43 - $83.43 $55,405 - $66,577	798 Added 5.75%	14,681 $1.21 Million
Q3 2023 Oct 04, 2023	BUY	$78.22 - $90.4 $63,358 - $73,224	810 Added 6.2%	13,883 $1.09 Million
Q2 2023 Jul 17, 2023	BUY	$79.47 - $91.38 $60,079 - $69,083	756 Added 6.14%	13,073 $1.15 Million
Q1 2023 Apr 13, 2023	BUY	$76.72 - $87.58 $408,457 - $466,275	5,324 Added 76.13%	12,317 $992,000
Q4 2022 Jan 20, 2023	SELL	$76.18 - $87.74 $104,823 - $120,730	-1,376 Reduced 16.44%	6,993 $0
Q3 2022 Nov 14, 2022	BUY	$80.75 - $95.31 $26,243 - $30,975	325 Added 4.04%	8,369 $676,000
Q2 2022 Jul 29, 2022	BUY	$87.4 - $113.09 $99,898 - $129,261	1,143 Added 16.56%	8,044 $722,000
Q1 2022 Apr 29, 2022	BUY	$100.58 - $112.38 $119,991 - $134,069	1,193 Added 20.9%	6,901 $766,000
Q4 2021 Jan 31, 2022	BUY	$99.53 - $127.75 $568,117 - $729,197	5,708 New	5,708 $594,000

Others Institutions Holding MDT

# of Institutions

2,243

Shares Held

1.04B

Call Options Held

7.1M

Put Options Held

4.42M

View Full List

About Medtronic plc

Ticker MDT
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 1,329,149,952
Market Cap $119B
Description
Medtronic plc develops, manufactures, and sells device-based medical therapies to healthcare systems, physicians, clinicians, and patients worldwide. Its Cardiovascular Portfolio segment offers implantable cardiac pacemakers, cardioverter defibrillators, and cardiac resynchronization therapy devices; cardiac ablation products; insertable cardiac...

More about MDT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Bowman & CO S.C., based on Form 13F filings with the SEC.

News

Stay updated on Bowman & CO S.C. with notifications on news.

Account